Fig. 13From: Significance of serum sestrin2 as a biomarker of severity and functional outcome in acute intracerebral hemorrhage: a prospective observational longitudinal studyDecision curve showing clinical benefit of prediction model of six-month poor prognosis following acute intracerebral hemorrhage. Prediction model containing serum sestrin2 levels, National Institutes of Health Stroke Scale scores and hematoma volume was clinically beneficial for predicting six-month poor prognosis after acute intracerebral hemorrhageBack to article page